Skip to Content
  • 1.8
    Impact Factor
  • 2.6
    CiteScore
  • 20 days
    Submission to First Decision
  • 5 days
    Acceptance to Publication

Biophysica

Biophysica is an international, peer-reviewed, open access journal on applying the methods of physics, chemistry, and math to study biological systems, published bimonthly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within  ESCI (Web of Science), Scopus, EBSCO, and other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 19.1 days after submission; acceptance to publication is undertaken in 4.7 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.
  • Biophysica is a companion journal of IJMS.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (354)

  • Article
  • Open Access

Background: Drug stability is a fundamental issue in drug-quality monitoring during storage. Methods: This study proposes a computational framework for degradation and potency estimation of pharmaceuticals using Raman spectroscopy. The absence of complete longitudinal Raman degradation data with experimental potencies led to the use of real Raman spectra as baseline spectra, which were then converted using physics-informed spectral degradation to create four stages (T0–T3). A modified 1D-Convolutional Neural Network (1D-CNN) comprising multi-scale convolution, residual learning, and spectral attention was designed to simultaneously classify the degradation stage and predict the remaining Active Pharmaceutical Ingredient potency. External computational testing of an independent set of commercial pharmaceutical dosage forms was performed using Raman data. The predicted potency profiles were further analyzed with an approximate zero-order kinetic model to estimate the degradation rate constant and the computational shelf-life t90. Results: The proposed modified 1D-CNN achieved better performance and an R2 value of 99.23 ± 0.02 for potency prediction, outperforming Support Vector Machine, Random Forest, and XGBoost models. From kinetic analysis, the R2 value was 0.98, the degradation rate constant was 5.78, and the calculated shelf-life was 1.76 normalized time units. Conclusions: The proposed framework can thus be considered as a computational proof-of-concept for Raman-based pharmaceutical degradation and potency assessment.

Biophysica

17 November 2026

Automated Pharmaceutical Drug Stability Assessment for Raman Spectral Analysis for Degradation and Remaining Potency Estimation.
  • Article
  • Open Access

Rocky Mountain spotted fever is a severe tick-borne disease caused by the intracellular bacteria Rickettsia rickettsii and vector-transmitted by the brown dog tick, Rhipicephalus sanguineus. No specific manifestations complicate timely diagnosis, underscoring the need for accessible serological antigens. Outer membrane proteins of R. rickettsii participate in host–pathogen interactions and represent promising diagnostic targets. This study integrated in silico structural and biophysical analyses with experimental approaches to characterize RrOmp17 and evaluate its IgG immunoreactivity. The RrOmp17 sequence and predicted three-dimensional structure were analyzed to identify candidate B-cell epitopes and characterize their surface accessibility and electrostatic environment. Recombinant RrOmp17 was produced in Escherichia coli, purified from inclusion bodies, subjected to stepwise refolding, and evaluated by Western blot for IgG recognition using human sera positive and negative for rickettsial disease. Bioinformatic analyses supported its classification as an outer membrane lipoprotein and revealed a C-terminal globular domain containing conserved, solvent-accessible candidate epitope regions with a predominantly positive electrostatic microenvironment. RrOmp17 was recognized by 21 of 26 Rickettsia-seropositive samples, whereas 27 of 29 comparison samples showed no detectable reactivity. Recognition across spotted fever and typhus groups suggests shared antigenic determinants. These findings link the molecular architecture and surface properties of RrOmp17 to its immunoreactivity and support its evaluation as a serological antigen in rickettsial infections.

Biophysica

14 November 2026

Multiple amino acid sequence alignment, conserved domain analysis of RrOmp17 and other homologous 17 kDa Omps from representative Rickettsia species, and in silico B-cell epitope mapping of RrOmp17. GenBank accession numbers for each sequence are as follows: R. rickettsii AAA26379, R. conorii AAA26376, R. parkeri QHF16169, R. africae WGZ75138, R. japonica Q52764, R. conorii subsp. heilongjiangensis BCS51664, R. amblyommatis AHZ64871, R. prowazekii AAA26378, R. typhi AAA26377, R. felis ADD11990, R. akari ABV75513, R. belii Q84I68, and R. canadensis ABV73985. Sequences are identified by Rickettsia etiological groups as: spotted fever group (red), typhus group (orange), transitional group (yellow), and ancestral group (green). In the alignment, background colors for each residue indicate: black (total identity, identical amino acid), gray (similarity, amino acid with similar chemical properties), and white (non-conserved or variable region, amino acid with distinct chemical properties). Consensus B-cell epitope regions identified by four prediction algorithms: BepiPred 3.0 (linear epitopes) in blue-purple cylinders; ElliPro (linear and conformational epitopes) in green and pink cylinders, respectively; SEMA 2.0 (conformational epitopes) in orange cylinders; and DiscoTope 3.0 (conformational epitopes) in red cylinders. Additionally, the input, output, and results of each algorithm are presented in Supplementary Table S1. The alignment references the numbering of the full-length RrOmp17 precursor (Met1–Asn159), while the positions of the predicted epitopes are indicated according to the mature protein (Cys1–Asn140). The bars shown represent epitope predictions from various computational algorithms, rather than experimentally validated ones.
  • Review
  • Open Access

Cancer continues to be the leading cause of death globally, with mounting evidence associating cellular stress with tumor initiation, progression, and therapeutic resistance. DNA damage-inducible transcript 3 (DDIT3), a key stress-responsive transcription factor, plays a central role in cellular stress responses by regulating apoptosis, cell survival, and the tumor microenvironment. Although DDIT3 has been extensively studied in neurodegenerative and metabolic diseases, its dual role in cancer has only recently begun to emerge. This review systematically explores the intricate functions of DDIT3 in cancer biology, emphasizing its involvement in endoplasmic reticulum (ER) stress, apoptosis regulation, and modulation of the tumor microenvironment. We investigate how DDIT3 interacts with key signaling pathways and its impact on cellular stress responses, such as autophagy and macrophage recruitment within the tumor microenvironment. Furthermore, we evaluate the therapeutic potential of targeting DDIT3 through clinical and preclinical drug studies, concentrating on compounds that enhance its pro-apoptotic functions or inhibit its cancer-promoting activities. This review seeks to provide a comprehensive understanding of DDIT3′s role in tumors, offering insights into future therapeutic strategies targeting this stress-related protein in oncology.

Biophysica

13 November 2026

The molecular structure of DDIT3. Note: in the last line of the figure, S is Serine; T is Threonine; G is Glycine; P is Proline.
  • Article
  • Open Access

Alzheimer’s disease (AD) is biologically heterogeneous, and plant-derived natural products provide chemically diverse starting points for multi-target discovery. Reproducible prioritization is needed to distinguish literature-supported evidence from candidate-specific predictions not yet generated. Our objective was to develop a reproducible, evidence-informed framework for prioritizing plant-derived natural products in AD and define a transparent candidate library and prespecified screening set for subsequent computational and experimental evaluation. Completed work included selection of an AD target panel (AChE/BChE, BACE1, GSK-3β and MAO-B), synthesis of a published target-specific machine-learning (ML) benchmark, curation of a 20-compound candidate library with traceable chemical identities and literature support, and selection of a 13-compound prespecified screening set. Published performance metrics were treated solely as external benchmark evidence. Study-specific model training, prospective ML screening, molecular docking, BBB/drug-likeness and ADMET evaluation, multi-objective ranking, and experimental validation were prespecified as future work and were not performed. The framework links mechanistically justified targets, published ML benchmarks, a chemically diverse 20-compound library, and a 13-compound set for future screening. The library includes evidence-rich reference compounds and comparatively underexplored scaffolds; no candidate-specific computational ranking or selection outcome is reported. This study presents an evidence-informed, multi-target computational framework for prioritizing plant-derived natural products in Alzheimer’s disease. Its methodological contribution lies in integrating a mechanistically defined target panel, published machine-learning benchmarks, a traceable 20-compound candidate library, and a prespecified 13-compound screening set within a transparent prospective evaluation strategy. By distinguishing completed framework-development activities from future computational and experimental analyses, the study establishes a structured foundation for subsequent model validation, multi-objective prioritization, and experimental investigation.

Biophysica

13 November 2026

Evidence-informed prioritization framework and prespecified prospective workflow for plant-derived natural products in Alzheimer’s disease. Stages 1–4 represent work completed in the present study, whereas stages 5–9 represent prespecified future analyses. Published ML performance metrics are treated solely as external benchmarking evidence; no candidate-specific ML predictions, docking results, BBB/ADMET predictions, rankings, or experimental outcomes were generated.

Featured Articles of Last Quarter

Chemical structure of LUT [17].
Basket (left panel) and flower (right panel) configurations of the Farapulse ablator (schematic illustration generated with the assistance of OpenAI ChatGPT (GPT-5.5)).
Time-dependent transformation of healthy, COVID-19, and sepsis oxidative inputs under the two structural mappings. (A) Phorbol 12-myristate 13-acetate (PMA)-constrained high-gain mapping, showing strong amplification of the disease-associated oxidative inputs. (B) Disease-saturating mapping, showing compression of the same oxidative inputs at higher oxidative burden.
Expected neural activity as a function of the number of synaptic connections μ, for firing thresholds θ = 8, θ = 12, θ = 16, and θ = 18.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Biophysica - ISSN 2673-4125